Promising Treatment for Deadly Cancer Blocked by Canadian Regulators See original press release on Newswire TORONTO, Aug. 19, 2020 /CNW Telbec/ – While innovations in health care are spurring extraordinary advances in the treatment of malignant tumours,...
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada’s research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of...
Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...
PCC Funded COMPASS Trial Leads to the Discovery of Five New Subtypes of Pancreatic Cancer We are excited to share the recent success of the COMPASS trial, a research study funded in part by Pancreatic Cancer Canada, that has announced the discovery of five distinct...
Dr. Anish Kirpalani, Pancreatic Cancer Canada’s board chair and a radiologist with 10 years of practice experience in Canada and the US, discusses the issues surrounding this most challenging form of cancer with Jane Brown on Zoomer Radio. Listen to the...
Alex Trebek encourages us all to get informed and involved during Pancreatic Cancer Awareness Month November is Pancreatic Cancer Awareness Month and Alex Trebek has a special message encouraging all of us to get involved in raising awareness and support for...
Recent Comments